Muscular Dystrophies: Genetic Testing, Diagnosis, and Carrier Screening
At a Glance
- Sample Required: Whole blood (EDTA) or DNA sample
- Fasting Rules: No fasting required
- Turnaround Time (TAT): 2–4 weeks for NGS panels
- Base Cost: [Insert Current 2026 Price]
Written by: Dr. A. Sharma, MD
Medically Reviewed by: Dr. R. Patel, Medical Geneticist
Last Updated: March 2026
Overview of Muscular Dystrophies
Muscular dystrophies are a heterogeneous group of inherited disorders characterized by progressive muscle weakness and degeneration. Most follow a Mendelian inheritance pattern, making genetic counseling essential. The clinical spectrum ranges from severe neonatal forms to adult-onset mild variants. Accurate molecular diagnosis is critical for management, prognosis, and reproductive planning.
Historically, diagnosis relied on muscle biopsy and immunohistochemistry. However, with the advent of next-generation sequencing (NGS), simultaneous analysis of multiple genes has become feasible, reducing the need for invasive procedures. DNA Labs India offers comprehensive NGS-based panels for muscular dystrophies, ensuring precise and timely results.
Types of Muscular Dystrophies
Duchenne Muscular Dystrophy (DMD)
DMD is an X-linked recessive disorder caused by mutations in the DMD gene at Xp21. It is the most common and severe form, affecting approximately 1 in 3,500 males. The gene is the largest known human gene, and about 60–70% of cases result from large deletions or duplications. NGS and MLPA (multiplex ligation-dependent probe amplification) detect these copy number variations with high accuracy.
Carrier detection in females is crucial for genetic counseling. DNA analysis can identify carriers with >99% sensitivity. Population screening of newborns using creatine kinase (CK) levels is debated, but molecular testing offers definitive diagnosis.
Becker Muscular Dystrophy (BMD)
BMD is a milder allelic variant of DMD, also caused by mutations in the DMD gene. Onset is later, and patients often remain ambulant into adulthood. Genetic testing is essential to distinguish BMD from other dystrophies and to assess carrier status in female relatives.
Other Progressive Muscular Dystrophies
This group includes Emery-Dreifuss muscular dystrophy (EMD), facioscapulohumeral dystrophy (FSHD), and limb-girdle muscular dystrophies (LGMD). Each has distinct genetic causes and inheritance patterns. NGS panels now enable simultaneous analysis of all known genes, streamlining diagnosis.
Spinal Muscular Atrophy (SMA)
SMA is an anterior horn cell disorder, not a primary myopathy, but often included in differential diagnosis. Over 95% of cases are due to homozygous deletions in the SMN1 gene on chromosome 5q. Genetic testing confirms the diagnosis and allows carrier screening.
Genetic Testing for Muscular Dystrophies at DNA Labs India
DNA Labs India, an ISO 9001 certified laboratory, offers comprehensive genetic testing for muscular dystrophies. Our tests utilize advanced NGS technology to detect point mutations, deletions, and duplications across all relevant genes.
| Test Name | Sample | TAT | Cost |
|---|---|---|---|
| Muscular Dystrophy NGS Panel | Blood (EDTA) | 3 weeks | [Insert Price] |
| DMD/BMD Deletion/Duplication (MLPA) | Blood (EDTA) | 2 weeks | [Insert Price] |
| SMA Carrier Screening (SMN1) | Blood (EDTA) | 1 week | [Insert Price] |
All tests include genetic counseling support and are performed in our ISO 9001 certified laboratory. Results are interpreted by board-certified geneticists.
Carrier Screening and Genetic Counseling
For X-linked disorders like DMD/BMD, carrier testing is essential for at-risk female relatives. Our comprehensive testing includes MLPA and NGS to identify carriers with high accuracy. For autosomal recessive conditions like SMA, carrier screening is recommended for couples planning pregnancy.
Genetic counseling is integral to the testing process. Our certified genetic counselors help families understand inheritance patterns, recurrence risks, and reproductive options, including prenatal diagnosis and preimplantation genetic testing.
Comparison of Muscular Dystrophy Types
| Type | Inheritance | Gene | Onset | Key Features |
|---|---|---|---|---|
| DMD | X-linked recessive | DMD | Early childhood | Proximal weakness, calf hypertrophy, cardiomyopathy |
| BMD | X-linked recessive | DMD | Adolescence/adulthood | Milder course, later onset |
| Emery-Dreifuss | X-linked or AD | EMD, LMNA | Childhood to adolescence | Contractures, cardiac conduction defects |
| FSHD | Autosomal dominant | D4Z4 repeat | Adolescence | Facial and shoulder weakness |
| LGMD | AR or AD | Multiple genes | Variable | Pelvic and shoulder girdle weakness |
| SMA | Autosomal recessive | SMN1 | Infancy to adulthood | Proximal muscle weakness, areflexia |